{"id":"https://openalex.org/W2561022367","doi":"https://doi.org/10.1007/s13311-016-0501-z","title":"Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot\u2013Marie\u2013Tooth Disease","display_name":"Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot\u2013Marie\u2013Tooth Disease","alternate_titles":[],"publication_year":2016,"publication_date":"2016-12-12","ids":{"openalex":"https://openalex.org/W2561022367","doi":"https://doi.org/10.1007/s13311-016-0501-z","mag":"2561022367","pmid":"https://pubmed.ncbi.nlm.nih.gov/27957719","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5398982"},"language":"en","primary_location":{"id":"doi:10.1007/s13311-016-0501-z","doi":"https://doi.org/10.1007/s13311-016-0501-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13311-016-0501-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13311-016-0501-z.pdf","source":{"id":"https://openalex.org/S75519821","display_name":"Neurotherapeutics","issn_l":"1878-7479","issn":["1878-7479","1933-7213"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2561022367"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s13311-016-0501-z.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066811413","display_name":"Veronick Benoy","orcid":"https://orcid.org/0000-0001-5551-5624","observed_orcids":["https://orcid.org/0000-0001-5551-5624"]},"institutions":[{"id":"https://openalex.org/I4210153928","display_name":"VIB-KU Leuven Center for Brain & Disease Research","ror":"https://ror.org/045c7t348","country_code":"BE","type":"facility","lineage":["https://openalex.org/I2802017950","https://openalex.org/I4210153928","https://openalex.org/I99464096"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Veronick Benoy","raw_affiliation_strings":["KU Leuven, Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), University of Leuven, B-3000, Leuven, Belgium","VIB, Center for Brain and Disease Research, Laboratory of Neurobiology, B-3000, Leuven, Belgium"],"raw_orcid":"https://orcid.org/0000-0001-5551-5624","affiliations":[{"raw_affiliation_string":"KU Leuven, Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), University of Leuven, B-3000, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"VIB, Center for Brain and Disease Research, Laboratory of Neurobiology, B-3000, Leuven, Belgium","institution_ids":["https://openalex.org/I4210153928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044812020","display_name":"Pieter Vanden Berghe","orcid":"https://orcid.org/0000-0002-0009-2094","observed_orcids":["https://orcid.org/0000-0002-0009-2094"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pieter Vanden Berghe","raw_affiliation_strings":["Translational Research Center for Gastrointestinal Disorders (TARGID), University of Leuven, B-3000 Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Research Center for Gastrointestinal Disorders (TARGID), University of Leuven, B-3000 Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013994463","display_name":"Matthew B. Jarpe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146766","display_name":"Acetylon Pharmaceuticals (United States)","ror":"https://ror.org/04re20p56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210146766"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matthew Jarpe","raw_affiliation_strings":["Acetylon Pharmaceuticals Inc., Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Acetylon Pharmaceuticals Inc., Boston, MA, USA","institution_ids":["https://openalex.org/I4210146766"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013023361","display_name":"Philip Van Damme","orcid":"https://orcid.org/0000-0002-4010-2357","observed_orcids":["https://orcid.org/0000-0002-4010-2357","https://orcid.org/0000-0001-6384-0611"]},"institutions":[{"id":"https://openalex.org/I4210153928","display_name":"VIB-KU Leuven Center for Brain & Disease Research","ror":"https://ror.org/045c7t348","country_code":"BE","type":"facility","lineage":["https://openalex.org/I2802017950","https://openalex.org/I4210153928","https://openalex.org/I99464096"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Philip Van Damme","raw_affiliation_strings":["Department of Neurology, University Hospitals Leuven, B-3000, Leuven, Belgium","KU Leuven, Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), University of Leuven, B-3000, Leuven, Belgium","VIB, Center for Brain and Disease Research, Laboratory of Neurobiology, B-3000, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University Hospitals Leuven, B-3000, Leuven, Belgium","institution_ids":[]},{"raw_affiliation_string":"KU Leuven, Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), University of Leuven, B-3000, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"VIB, Center for Brain and Disease Research, Laboratory of Neurobiology, B-3000, Leuven, Belgium","institution_ids":["https://openalex.org/I4210153928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109084436","display_name":"Wim Robberecht","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wim Robberecht","raw_affiliation_strings":["Department of Neurology, University Hospitals Leuven, B-3000, Leuven, Belgium","KU Leuven, Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), University of Leuven, B-3000, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University Hospitals Leuven, B-3000, Leuven, Belgium","institution_ids":[]},{"raw_affiliation_string":"KU Leuven, Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), University of Leuven, B-3000, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069828577","display_name":"Ludo Van Den Bosch","orcid":"https://orcid.org/0000-0003-0104-4067","observed_orcids":["https://orcid.org/0000-0003-0104-4067"]},"institutions":[{"id":"https://openalex.org/I4210153928","display_name":"VIB-KU Leuven Center for Brain & Disease Research","ror":"https://ror.org/045c7t348","country_code":"BE","type":"facility","lineage":["https://openalex.org/I2802017950","https://openalex.org/I4210153928","https://openalex.org/I99464096"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ludo Van Den Bosch","raw_affiliation_strings":["KU Leuven, Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), University of Leuven, B-3000, Leuven, Belgium. ludo.vandenbosch@vib-kuleuven.be","VIB, Center for Brain and Disease Research, Laboratory of Neurobiology, B-3000, Leuven, Belgium. ludo.vandenbosch@vib-kuleuven.be","VIB, Center for Brain and Disease Research, Laboratory of Neurobiology, B-3000, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KU Leuven, Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), University of Leuven, B-3000, Leuven, Belgium. ludo.vandenbosch@vib-kuleuven.be","institution_ids":["https://openalex.org/I4210153928","https://openalex.org/I99464096"]},{"raw_affiliation_string":"VIB, Center for Brain and Disease Research, Laboratory of Neurobiology, B-3000, Leuven, Belgium. ludo.vandenbosch@vib-kuleuven.be","institution_ids":["https://openalex.org/I4210153928"]},{"raw_affiliation_string":"VIB, Center for Brain and Disease Research, Laboratory of Neurobiology, B-3000, Leuven, Belgium","institution_ids":["https://openalex.org/I4210153928"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5069828577"],"corresponding_institution_ids":["https://openalex.org/I4210153928","https://openalex.org/I99464096"],"apc_list":{"value":3900,"currency":"USD","value_usd":3900},"apc_paid":{"value":3900,"currency":"USD","value_usd":3900},"fwci":2.7797,"has_fulltext":true,"cited_by_count":91,"citation_normalized_percentile":{"value":0.90891647,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"14","issue":"2","first_page":"417","last_page":"428"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12331","display_name":"Hereditary Neurological Disorders","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12331","display_name":"Hereditary Neurological Disorders","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/charcot-marie-tooth-disease-type-2","display_name":"Charcot-Marie-Tooth disease type 2","score":0.9430000185966492},{"id":"https://openalex.org/keywords/hdac6-inhibitors","display_name":"HDAC6 inhibitors","score":0.9369999766349792},{"id":"https://openalex.org/keywords/hdac6","display_name":"HDAC6","score":0.9259999990463257},{"id":"https://openalex.org/keywords/alpha-tubulin-deacetylation","display_name":"alpha-tubulin deacetylation","score":0.9120000004768372},{"id":"https://openalex.org/keywords/hspb1","display_name":"HSPB1","score":0.765999972820282},{"id":"https://openalex.org/keywords/acy-1215","display_name":"ACY-1215","score":0.8180000185966492},{"id":"https://openalex.org/keywords/nerve-conduction","display_name":"nerve conduction","score":0.8100000023841858},{"id":"https://openalex.org/keywords/axon-degeneration","display_name":"axonal degeneration","score":0.7440000176429749},{"id":"https://openalex.org/keywords/peripheral-neuropathy","display_name":"peripheral neuropathy","score":0.843999981880188},{"id":"https://openalex.org/keywords/drug-screening","display_name":"drug screening","score":0.5950000286102295}],"concepts":[{"id":"https://openalex.org/C23681527","wikidata":"https://www.wikidata.org/wiki/Q18034953","display_name":"HDAC6","level":5,"score":0.7975403070449829},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5526903867721558},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5017869472503662},{"id":"https://openalex.org/C16568411","wikidata":"https://www.wikidata.org/wiki/Q83042","display_name":"Neurology","level":2,"score":0.4793054163455963},{"id":"https://openalex.org/C2776752467","wikidata":"https://www.wikidata.org/wiki/Q1133903","display_name":"Motor neuron","level":3,"score":0.41081559658050537},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.33455994725227356},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32502490282058716},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3063424229621887},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2715945839881897},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.2076193392276764},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09189245104789734},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000073864","descriptor_name":"Histone Deacetylase 6","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001370","descriptor_name":"Axonal Transport","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002607","descriptor_name":"Charcot-Marie-Tooth Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002607","descriptor_name":"Charcot-Marie-Tooth Disease","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005727","descriptor_name":"Ganglia, Spinal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006877","descriptor_name":"Hydroxamic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009469","descriptor_name":"Neuromuscular Junction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018482","descriptor_name":"Muscle, Skeletal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018482","descriptor_name":"Muscle, Skeletal","qualifier_ui":"Q000294","qualifier_name":"innervation","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1007/s13311-016-0501-z","doi":"https://doi.org/10.1007/s13311-016-0501-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13311-016-0501-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13311-016-0501-z.pdf","source":{"id":"https://openalex.org/S75519821","display_name":"Neurotherapeutics","issn_l":"1878-7479","issn":["1878-7479","1933-7213"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"journal-article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/561185","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/561185","pdf_url":"https://lirias.kuleuven.be/retrieve/876c3050-edf7-4b60-8974-8fc83db4babe","source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics, vol. 14 (2), (417-428)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:europepmc.org:4267641","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5398982","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5398982","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5398982/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"Text"},{"id":"pmid:27957719","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27957719","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s13311-016-0501-z","doi":"https://doi.org/10.1007/s13311-016-0501-z","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13311-016-0501-z","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13311-016-0501-z.pdf","source":{"id":"https://openalex.org/S75519821","display_name":"Neurotherapeutics","issn_l":"1878-7479","issn":["1878-7479","1933-7213"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurotherapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6728234220","display_name":"Optimization of HDAC6 Inhibitors in the Treatment of CMT","funder_award_id":"R01NS079183","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G8709469716","display_name":"European multidisciplinary ALS network identification to cure motor neuron degeneration","funder_award_id":"259867","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"}],"funders":[{"id":"https://openalex.org/F4320308306","display_name":"Muscular Dystrophy Association","ror":"https://ror.org/01frxsf98"},{"id":"https://openalex.org/F4320309731","display_name":"Association Belge contre les Maladies Neuro-Musculaires","ror":"https://ror.org/02yr31a60"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320321454","display_name":"Belgian Federal Science Policy Office","ror":"https://ror.org/01fapfv42"},{"id":"https://openalex.org/F4320321730","display_name":"Fonds Wetenschappelijk Onderzoek","ror":"https://ror.org/03qtxy027"},{"id":"https://openalex.org/F4320322308","display_name":"KU Leuven","ror":"https://ror.org/05f950310"},{"id":"https://openalex.org/F4320327336","display_name":"Vlaamse regering","ror":null},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2561022367.pdf","grobid_xml":"https://content.openalex.org/works/W2561022367.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W1023820744","https://openalex.org/W1530963662","https://openalex.org/W1551233310","https://openalex.org/W1846838131","https://openalex.org/W1965759164","https://openalex.org/W1972380090","https://openalex.org/W1981259598","https://openalex.org/W1982045496","https://openalex.org/W1982659220","https://openalex.org/W1991660464","https://openalex.org/W1992593169","https://openalex.org/W2009826707","https://openalex.org/W2013380493","https://openalex.org/W2016509332","https://openalex.org/W2026165513","https://openalex.org/W2038557487","https://openalex.org/W2039073478","https://openalex.org/W2040841210","https://openalex.org/W2046439284","https://openalex.org/W2046746554","https://openalex.org/W2050996088","https://openalex.org/W2051469259","https://openalex.org/W2063078660","https://openalex.org/W2064959533","https://openalex.org/W2067089499","https://openalex.org/W2073996202","https://openalex.org/W2090926709","https://openalex.org/W2092706716","https://openalex.org/W2095026025","https://openalex.org/W2101127235","https://openalex.org/W2107334796","https://openalex.org/W2107733280","https://openalex.org/W2110633413","https://openalex.org/W2112959936","https://openalex.org/W2114716596","https://openalex.org/W2126118258","https://openalex.org/W2137894294","https://openalex.org/W2152209190","https://openalex.org/W2155105134","https://openalex.org/W2161164503","https://openalex.org/W2164604342","https://openalex.org/W2173331185","https://openalex.org/W2179490146","https://openalex.org/W2222120895","https://openalex.org/W2232967179","https://openalex.org/W2262207279","https://openalex.org/W2265913260","https://openalex.org/W2396184091","https://openalex.org/W2520638688","https://openalex.org/W2528988294","https://openalex.org/W6663393298","https://openalex.org/W6677339484"],"related_works":["https://openalex.org/W2526775330","https://openalex.org/W2173331185","https://openalex.org/W3003640803","https://openalex.org/W2110633413","https://openalex.org/W3049429057","https://openalex.org/W6991535090","https://openalex.org/W2416681201","https://openalex.org/W3010355643","https://openalex.org/W2073996202"],"abstract_inverted_index":{"Charcot-Marie-Tooth":[0],"disease":[1],"(CMT)":[2],"is":[3,50,205,214,221],"the":[4,42,77,83,102,150,154,183,186,190,195,236],"most":[5],"common":[6],"inherited":[7],"peripheral":[8],"neuropathy,":[9],"with":[10],"an":[11,38,215],"estimated":[12],"prevalence":[13],"of":[14,20,45,76,80,141,185,238,241],"1":[15],"in":[16,70,88,153,189,210,224],"2500.":[17],"The":[18],"degeneration":[19],"motor":[21,28,84,196],"and":[22,29,36,85,104,125,145,165,169,175,193,197],"sensory":[23,30,86,198],"nerve":[24,199],"axons":[25],"leads":[26],"to":[27,109,171],"symptoms":[31],"that":[32,122,139,146,202],"progress":[33],"over":[34],"time":[35],"have":[37],"important":[39],"impact":[40],"on":[41,149],"daily":[43],"life":[44],"these":[46,180,231],"patients.":[47],"Currently,":[48],"there":[49],"no":[51],"curative":[52],"treatment":[53],"available.":[54],"Recently,":[55],"we":[56,135],"identified":[57],"histone":[58],"deacetylase":[59],"6":[60],"(HDAC6),":[61],"which":[62],"deacetylates":[63],"\u03b1-tubulin,":[64],"as":[65,219],"a":[66,89,116,137,206,244],"potential":[67,112,207],"therapeutic":[68,113,208],"target":[69],"axonal":[71],"CMT":[72],"(CMT2).":[73],"Pharmacological":[74],"inhibition":[75,204,240],"deacetylating":[78],"function":[79],"HDAC6":[81,127,177,203,242],"reversed":[82],"deficits":[87],"mouse":[90,158],"model":[91],"for":[92,133,227],"mutant":[93,155],"\"small":[94],"heat":[95],"shock":[96],"protein":[97],"B1\"":[98],"(HSPB1)-induced":[99],"CMT2":[100,157],"at":[101],"behavioral":[103],"electrophysiological":[105],"level.":[106],"In":[107],"order":[108],"translate":[110],"this":[111],"strategy":[114,209],"into":[115,243],"clinical":[117,225],"application,":[118],"small":[119],"drug-like":[120],"molecules":[121],"are":[123,129],"potent":[124,174],"selective":[126,176],"inhibitors":[128,162,181],"essential.":[130],"To":[131],"screen":[132],"these,":[134],"developed":[136],"method":[138],"consisted":[140],"3":[142],"distinct":[143],"phases":[144],"was":[147],"based":[148],"pathological":[151],"findings":[152],"HSPB1-induced":[156],"model.":[159],"Three":[160],"different":[161],"(ACY-738,":[163],"ACY-775,":[164],"ACY-1215)":[166],"were":[167],"tested":[168,223],"demonstrated":[170],"be":[172],"both":[173],"inhibitors.":[178],"Moreover,":[179],"increased":[182],"innervation":[184],"neuromuscular":[187],"junctions":[188],"gastrocnemius":[191],"muscle":[192],"improved":[194],"conduction,":[200],"confirming":[201],"CMT2.":[211,247],"Furthermore,":[212],"ACY-1215":[213],"interesting":[216],"lead":[217],"molecule":[218],"it":[220],"currently":[222],"trials":[226],"cancer.":[228],"Taken":[229],"together,":[230],"results":[232],"may":[233],"speed":[234],"up":[235],"translation":[237],"pharmacological":[239],"therapy":[245],"against":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2561022367","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-01-06T00:00:00"}
